Published in Laryngoscope on February 08, 2011
B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A (2010) 2.03
Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery (2005) 1.76
A novel orthotopic mouse model of human anaplastic thyroid carcinoma. Thyroid (2009) 1.53
BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression. Cancer Res (2011) 1.47
Carcinoid tumors in the breast. Am J Surg (2006) 1.41
Effect of rapamycin alone and in combination with antiangiogenesis therapy in an orthotopic model of human pancreatic cancer. Clin Cancer Res (2004) 1.31
Thrombospondin-1 modulates vascular endothelial growth factor activity at the receptor level. FASEB J (2009) 1.29
Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer. Oncologist (2011) 1.27
AACE/ACE disease state commentary: molecular diagnostic testing of thyroid nodules with indeterminate cytopathology. Endocr Pract (2014) 1.24
Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E). Biochim Biophys Acta (2009) 1.18
Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer. Endocrinology (2011) 1.13
Ultrasound-guided percutaneous thyroid nodule core biopsy: clinical utility in patients with prior nondiagnostic fine-needle aspirate. Thyroid (2012) 1.03
Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line. Biochem Biophys Res Commun (2003) 1.02
Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer. Surgery (2010) 1.00
BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence. Surgery (2012) 0.99
A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR. Cancer Res (2009) 0.99
Hemorrhagic cholecystitis simulating gallbladder carcinoma. J Ultrasound Med (2004) 0.99
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? Oncotarget (2010) 0.98
Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin. Clin Cancer Res (2007) 0.97
Best cases from the AFIP: paraganglioma of the organs of Zuckerkandl. Radiographics (2003) 0.96
Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid (2010) 0.96
The thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. Semin Ultrasound CT MR (2005) 0.95
The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1. Blood (2013) 0.93
Antiangiogenic treatment with three thrombospondin-1 type 1 repeats versus gemcitabine in an orthotopic human pancreatic cancer model. Clin Cancer Res (2005) 0.93
Antiangiogenic treatment with the three thrombospondin-1 type 1 repeats recombinant protein in an orthotopic human pancreatic cancer model. Clin Cancer Res (2005) 0.92
Thyroid surgery in octogenarians is associated with higher complication rates. Surgery (2009) 0.92
Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy. Ann Surg Oncol (2012) 0.91
Summary statement: utility of molecular marker testing in thyroid cancer. Surgery (2010) 0.90
Hyalinizing trabecular adenoma--an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma. Am J Surg (2007) 0.89
Accuracy of 4-dimensional computed tomography in poorly localized patients with primary hyperparathyroidism. Surgery (2010) 0.88
Management of thyroid incidentalomas. Surg Clin North Am (2004) 0.88
Thyroid incidentalomas: a new epidemic. Curr Surg (2004) 0.88
Resident/fellow assistance in the operating room for endocrine surgery in the era of fellowships. Surgery (2010) 0.85
Continuous administration of the three thrombospondin-1 type 1 repeats recombinant protein improves the potency of therapy in an orthotopic human pancreatic cancer model. Cancer Lett (2006) 0.85
Angiogenesis in benign and malignant thyroid disease. Thyroid (2005) 0.84
Medical and surgical risks in thyroid surgery: lessons from the NSQIP. Ann Surg Oncol (2011) 0.82
Surgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules. Am J Surg (2010) 0.82
Bilaterality in papillary thyroid carcinoma: does it influence prognosis? Ann Surg Oncol (2012) 0.81
Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer. Surgery (2013) 0.81
Multiple signaling is involved in endostatin-mediated apoptosis in ECV 304 endothelial cells. Front Biosci (2005) 0.80
Intraoperative parathyroid hormone testing: what have we learned? Laryngoscope (2003) 0.80
Diagnostic yield of nondiagnostic thyroid nodules is not altered by timing of repeat biopsy. Thyroid (2012) 0.80
The next generation of orthotopic thyroid cancer models: immunocompetent orthotopic mouse models of BRAF V600E-positive papillary and anaplastic thyroid carcinoma. Thyroid (2014) 0.78
Parathyroid hormone response to tracheal intubation in hyperparathyroid patients and normal subjects. Endocr J (2005) 0.78
Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment. J Nucl Med (2002) 0.78
The Bethesda System for Reporting Thyroid Cytopathology: Proposed Modifications and Updates for the Second Edition from an International Panel. Acta Cytol (2016) 0.77
Case records of the Massachusetts General Hospital: Case 38-2010: a 13-year-old girl with an enlarging neck mass. N Engl J Med (2010) 0.77
A potential role for immunotherapy in thyroid cancer by enhancing NY-ESO-1 cancer antigen expression. Thyroid (2014) 0.77
When initial postexcision PTH level does not fall appropriately during parathyroidectomy: what to do next? World J Surg (2009) 0.76
Laparoscopic adrenalectomy for pheochromocytoma. Curr Surg (2004) 0.76
Image of the month: acute and chronic cholecystitis with abscess formation. Arch Surg (2006) 0.75
Partial thyroidectomy: illustrated reflections for surgical residents. Curr Surg (2005) 0.75
Surgery for Graves' disease: a 25-year perspective. Am J Surg (2013) 0.75
Parathyroid carcinoma and neurofibromatosis. Surgery (2008) 0.75
Surgical drains can be safely avoided in lateral neck dissections for papillary thyroid cancer. Am J Surg (2010) 0.75
The gene expression and activity of calpains and the muscle wasting-associated ubiquitin ligases, atrogin-1 and MuRF1, are not altered in patients with primary hyperparathyroidism. Int J Mol Med (2006) 0.75
Image of the month. Enterolithotomy. Arch Surg (2006) 0.75
Case records of the Massachusetts General Hospital. Case 10-2015. A 15-year-old girl with Graves’ disease and psychotic symptoms. N Engl J Med (2015) 0.75
Quantification of vascular endothelial cell apoptosis in vivo. Methods Enzymol (2008) 0.75
IPMN and parathyroid adenoma: an interesting association. JOP (2012) 0.75
Preface: Head and neck ultrasound. Otolaryngol Clin North Am (2010) 0.75